Characterization of antibodies against core, NS3, NS4, NS5 region of hepatitis C virus in patients with hepatitis C

K. Ishii, M. Ishibashi, T. Ohtake, S. Kano, Hidetsugu Saito, K. Watanabe

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Third-generation screening assays for HCV antibodies were recently developed, in which a mixture of recombinant antigens from four different regions of the viral protein (core, NS3, NS4, NS5) was used. We reported the analytical performance and clinical usefulness of a third-generation counting immunoassay (RANREAM HCV) with PAMIA 30 (Toa Medical Electronics Inc., Kobe). In the present study, we investigated a modified assay of RANREAM HCV to detect region-specific antibody by using single antigen from four different regions, and studied response pattern of HCV antibodies and region-specific antibody in the patients with HCV infection. HCV antibodies of the seroconversion panel serum samples (BBI, USA) measured by RANREAM HCV were greatly coincident with those obtained by Ortho RIBA 3.0. The region-specific assay of serial sera from the patient with acute hepatitis revealed that anti-core antibody was produced at the initial stage of infection. In 165 patients with chronic hepatitis, pattern of region-specific antibody was different from case to case, although anti-NS3 and anti-core antibodies seemed to be predominant. The change of pattern was not observed for at least one year. All 2 cases who achieved complete remission with interferon showed low serum titer of anti-core antibody, in contrast to partial or non remission patients in which the level of anti-core antibodies was low in 6 of 16 cases.

Original languageEnglish
Pages (from-to)1156-1162
Number of pages7
JournalRinsho byori. The Japanese journal of clinical pathology
Volume45
Issue number12
Publication statusPublished - 1997

Fingerprint

Hepatitis C
Hepacivirus
Hepatitis C Antibodies
Anti-Idiotypic Antibodies
Antibodies
Serum
Medical Electronics
Viral Core Proteins
Antigens
Chronic Hepatitis
Infection
Immunoassay
Interferons
Hepatitis

Cite this

Characterization of antibodies against core, NS3, NS4, NS5 region of hepatitis C virus in patients with hepatitis C. / Ishii, K.; Ishibashi, M.; Ohtake, T.; Kano, S.; Saito, Hidetsugu; Watanabe, K.

In: Rinsho byori. The Japanese journal of clinical pathology, Vol. 45, No. 12, 1997, p. 1156-1162.

Research output: Contribution to journalArticle

@article{d6b7002ecf854b549c56307e926c4143,
title = "Characterization of antibodies against core, NS3, NS4, NS5 region of hepatitis C virus in patients with hepatitis C",
abstract = "Third-generation screening assays for HCV antibodies were recently developed, in which a mixture of recombinant antigens from four different regions of the viral protein (core, NS3, NS4, NS5) was used. We reported the analytical performance and clinical usefulness of a third-generation counting immunoassay (RANREAM HCV) with PAMIA 30 (Toa Medical Electronics Inc., Kobe). In the present study, we investigated a modified assay of RANREAM HCV to detect region-specific antibody by using single antigen from four different regions, and studied response pattern of HCV antibodies and region-specific antibody in the patients with HCV infection. HCV antibodies of the seroconversion panel serum samples (BBI, USA) measured by RANREAM HCV were greatly coincident with those obtained by Ortho RIBA 3.0. The region-specific assay of serial sera from the patient with acute hepatitis revealed that anti-core antibody was produced at the initial stage of infection. In 165 patients with chronic hepatitis, pattern of region-specific antibody was different from case to case, although anti-NS3 and anti-core antibodies seemed to be predominant. The change of pattern was not observed for at least one year. All 2 cases who achieved complete remission with interferon showed low serum titer of anti-core antibody, in contrast to partial or non remission patients in which the level of anti-core antibodies was low in 6 of 16 cases.",
author = "K. Ishii and M. Ishibashi and T. Ohtake and S. Kano and Hidetsugu Saito and K. Watanabe",
year = "1997",
language = "English",
volume = "45",
pages = "1156--1162",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "12",

}

TY - JOUR

T1 - Characterization of antibodies against core, NS3, NS4, NS5 region of hepatitis C virus in patients with hepatitis C

AU - Ishii, K.

AU - Ishibashi, M.

AU - Ohtake, T.

AU - Kano, S.

AU - Saito, Hidetsugu

AU - Watanabe, K.

PY - 1997

Y1 - 1997

N2 - Third-generation screening assays for HCV antibodies were recently developed, in which a mixture of recombinant antigens from four different regions of the viral protein (core, NS3, NS4, NS5) was used. We reported the analytical performance and clinical usefulness of a third-generation counting immunoassay (RANREAM HCV) with PAMIA 30 (Toa Medical Electronics Inc., Kobe). In the present study, we investigated a modified assay of RANREAM HCV to detect region-specific antibody by using single antigen from four different regions, and studied response pattern of HCV antibodies and region-specific antibody in the patients with HCV infection. HCV antibodies of the seroconversion panel serum samples (BBI, USA) measured by RANREAM HCV were greatly coincident with those obtained by Ortho RIBA 3.0. The region-specific assay of serial sera from the patient with acute hepatitis revealed that anti-core antibody was produced at the initial stage of infection. In 165 patients with chronic hepatitis, pattern of region-specific antibody was different from case to case, although anti-NS3 and anti-core antibodies seemed to be predominant. The change of pattern was not observed for at least one year. All 2 cases who achieved complete remission with interferon showed low serum titer of anti-core antibody, in contrast to partial or non remission patients in which the level of anti-core antibodies was low in 6 of 16 cases.

AB - Third-generation screening assays for HCV antibodies were recently developed, in which a mixture of recombinant antigens from four different regions of the viral protein (core, NS3, NS4, NS5) was used. We reported the analytical performance and clinical usefulness of a third-generation counting immunoassay (RANREAM HCV) with PAMIA 30 (Toa Medical Electronics Inc., Kobe). In the present study, we investigated a modified assay of RANREAM HCV to detect region-specific antibody by using single antigen from four different regions, and studied response pattern of HCV antibodies and region-specific antibody in the patients with HCV infection. HCV antibodies of the seroconversion panel serum samples (BBI, USA) measured by RANREAM HCV were greatly coincident with those obtained by Ortho RIBA 3.0. The region-specific assay of serial sera from the patient with acute hepatitis revealed that anti-core antibody was produced at the initial stage of infection. In 165 patients with chronic hepatitis, pattern of region-specific antibody was different from case to case, although anti-NS3 and anti-core antibodies seemed to be predominant. The change of pattern was not observed for at least one year. All 2 cases who achieved complete remission with interferon showed low serum titer of anti-core antibody, in contrast to partial or non remission patients in which the level of anti-core antibodies was low in 6 of 16 cases.

UR - http://www.scopus.com/inward/record.url?scp=0031305190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031305190&partnerID=8YFLogxK

M3 - Article

C2 - 9437896

AN - SCOPUS:0031305190

VL - 45

SP - 1156

EP - 1162

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 12

ER -